Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Motor unit number estimation, isometric strength, and electromyographic measures in amyotrophic lateral sclerosis

View through CrossRef
AbstractPathologic progression in amyotrophic lateral sclerosis (ALS) results from motor neuron death, while the clinical expression also reflects the compensatory effects of collateral reinnervation consequent to lower motor neuron loss. In a cross‐sectional study of ALS subjects, we made comparisons between motor unit number estimation (MUNE) values and several measures reflecting collateral reinnervation, including isometric strength, compound muscle action potential (CMAP) amplitude, surface motor unit action potential (S‐MUAP) amplitude, fiber density (FD), macro‐EMG potential amplitude, turns‐to‐amplitude (T/A) ratio, and amplitude and recruitment pattern of low threshold voluntary motor units in elbow flexor muscles. Before comparisons were made, testretest reproducibility of these measures was assessed in ALS subjects, and is highest for isometric strength, and lower but similar for EMG measures. When the effects of multiple comparisons are considered, borderline significant correlations are found between MUNE values and isometric strength. Neither MUNE values nor isometric strength are significantly correlated with macro‐EMG amplitude, FD, T/A ratio, or amplitude and recruitment rate of low threshold voluntary motor units. There are significant correlations of CMAP and S‐MUAP with MUNE values, but these are statistical artifacts with no independent interpretation. We conclude that collateral reinnervation prevents isometric strength and EMG measures from accurately reflecting lower motor neuron death in ALS. MUNE measurements are better suited to provide insight into the true natural history of the disease process and may be clinically useful to follow progression and response in drug trials. © 1993 John Wiley & Sons, Inc.
Title: Motor unit number estimation, isometric strength, and electromyographic measures in amyotrophic lateral sclerosis
Description:
AbstractPathologic progression in amyotrophic lateral sclerosis (ALS) results from motor neuron death, while the clinical expression also reflects the compensatory effects of collateral reinnervation consequent to lower motor neuron loss.
In a cross‐sectional study of ALS subjects, we made comparisons between motor unit number estimation (MUNE) values and several measures reflecting collateral reinnervation, including isometric strength, compound muscle action potential (CMAP) amplitude, surface motor unit action potential (S‐MUAP) amplitude, fiber density (FD), macro‐EMG potential amplitude, turns‐to‐amplitude (T/A) ratio, and amplitude and recruitment pattern of low threshold voluntary motor units in elbow flexor muscles.
Before comparisons were made, testretest reproducibility of these measures was assessed in ALS subjects, and is highest for isometric strength, and lower but similar for EMG measures.
When the effects of multiple comparisons are considered, borderline significant correlations are found between MUNE values and isometric strength.
Neither MUNE values nor isometric strength are significantly correlated with macro‐EMG amplitude, FD, T/A ratio, or amplitude and recruitment rate of low threshold voluntary motor units.
There are significant correlations of CMAP and S‐MUAP with MUNE values, but these are statistical artifacts with no independent interpretation.
We conclude that collateral reinnervation prevents isometric strength and EMG measures from accurately reflecting lower motor neuron death in ALS.
MUNE measurements are better suited to provide insight into the true natural history of the disease process and may be clinically useful to follow progression and response in drug trials.
© 1993 John Wiley & Sons, Inc.

Related Results

Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration
Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration
Abstract TDP-43 is mislocalized from the nucleus and aggregates within the cytoplasm of affected neurons in cases of amyotrophic lateral sclerosis. TDP-43 pathology ...
Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis
Abstract Amyotrophic lateral sclerosis is a progressive neurodegenerative syndrome characterized by loss of motor neurons. Cognit...
Amyotrophic lateral sclerosis: Neural repair strategies based on multi-target synchronous interventions
Amyotrophic lateral sclerosis: Neural repair strategies based on multi-target synchronous interventions
Abstract Amyotrophic lateral sclerosis is a progressive and fatal neurodegenerative disease that targets motor neurons in the cerebral cortex, medulla oblongata, ...
Urinary biomarkers for amyotrophic lateral sclerosis: candidates, opportunities and considerations
Urinary biomarkers for amyotrophic lateral sclerosis: candidates, opportunities and considerations
Abstract Amyotrophic lateral sclerosis is a relentless neurodegenerative disease that is mostly fatal within 3–5 years and is diagnosed on evidence of progressive up...
Amyotrophic Lateral Sclerosis and its Masks, a Comorbid Pathology with a Rapid Fatal Outcome: Case Report
Amyotrophic Lateral Sclerosis and its Masks, a Comorbid Pathology with a Rapid Fatal Outcome: Case Report
INTRODUCTION. Despite the fact that more than 150 years have passed since the first mention of amyotrophic lateral sclerosis (ALS), the issues of etiology, pathogenesis, diagnosis ...
Energy cost of isometric force production after active shortening in skinned muscle fibres
Energy cost of isometric force production after active shortening in skinned muscle fibres
The steady state isometric force after active shortening of a skeletal muscle is lower than the purely isometric force at the corresponding length. This property of skeletal muscle...
Safety and efficacy of edaravone in well-defined Iranian patients with amyotrophic lateral sclerosis: A parallel-group single-blind trial
Safety and efficacy of edaravone in well-defined Iranian patients with amyotrophic lateral sclerosis: A parallel-group single-blind trial
Background: This parallel-group single-blind trial evaluates the safety and efficacy of Edaravone, as a free radical scavenger, in a highly selective subgroup of Iranian patients w...

Back to Top